SCHEMBL6945649

SCHEMBL6945649

CCCc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.41
ALDH1A1 P00352 9/20 0.40
KDM4E B2RXH2 9/20 0.40
HPGD P15428 6/20 0.40
MAPT P10636 4/20 0.40
HSD17B10 Q99714 3/20 0.39
GAA P10253 2/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
HIF1A Q16665 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM2 Q14416 1/20 0.38
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951302 0.89 PDE9A (0.40) PDE9AALDH1A1KDM4EHPGDMAPT
SCHEMBL6945691 0.89 PDE9A (0.45) PDE9AALDH1A1KDM4EHPGDMAPT
SCHEMBL6952723 0.86 PDE9A (0.44) PDE9AALDH1A1KDM4EHPGDMAPT
SCHEMBL6952968 0.84 HTR1A (0.41) PDE9AALDH1A1KDM4EHPGDMAPT
SCHEMBL6953105 0.83 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6951286 0.82 PDE9A (0.40) PDE9AALDH1A1KDM4EHPGDMAPT
SCHEMBL6949962 0.82 GAA (0.43) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6951832 0.81 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6955411 0.81 RXFP1 (0.54) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6949420 0.81 DAO (0.40) PDE9AALDH1A1KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed